Health, biotech and agriculture

Anhui Anke Biotechnology安科生物

Standard profile, compiled by hefei.be from public sourcesbiopharmaceuticalsinterferongrowth hormonediagnostics

About the company

Anhui Anke Biotechnology develops and manufactures genetically engineered drugs such as human interferon α2b and human growth hormone, as well as trastuzumab for injection and reproductive-health diagnostic kits. Founded in 1993, it was among the first companies listed on Shenzhen’s ChiNext board in 2009. Headquartered in the Hefei High-tech Zone, it reported 2025 revenue of 2.65 billion yuan and net profit of 735 million yuan.

Video

No video yet. A company video is an add-on for companies with a profile.

Presentation

No presentation yet. A company presentation is an add-on for companies with a profile.

News

No news yet. Once the company claims its profile, hefei.be follows the news on the company website and whatever the company approves appears here.

Partnerships on hefei.be

No confirmed partnerships yet. A partnership only appears once both companies confirm it.